Wnt signaling in regulation of stem cells

Chemical Biology in Regenerative Medicine: Bridging Stem Cells and Future Therapies

Volumn , Issue , 2014, Pages 1-14

  Paik, David T ^a   Hatzopoulos, Antonis K ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Cardiac progenitor cell (CPC); Dickkopf related protein 1 (Dkk 1); Embryonic stem cell (ESC); Endothelial mesenchymal transition (EndMT); Frizzled (Fzd); Hematopoietic stem cell (HSC); Mesenchymal stem cell (MSC); Sfrp 2; Wnt signaling; Wnt10b; Wnt11; Wnt3a; catenin

Indexed keywords

EID: 85016003397     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118695746.ch1     Document Type: Chapter

References (94)

1. Van Amerongen, R. and Nusse, R. (2009) Towards an integrated view of Wnt signaling in development. Development (Cambridge England), 136 (19), 3205-3214.
2. Rao, T.P. and Kuhl, M. (2010) An updated overview on Wnt signaling pathways: a prelude for more. Circulation Research, 106 (12), 1798-1806.
3. Nusse, R. (2008) Wnt signaling and stem cell control. Cell Research, 18 (5), 523-527.
4. MacDonald, B.T., Tamai, K., and He, X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Developmental Cell, 17 (1), 9-26.
5. Jho, E., Zhang, T., Domon, C., et al. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Molecular and Cellular Biology, 22 (4), 1172-1183.
6. He, T.C., Sparks, A.B., Rago, C., et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281 (5382), 1509-1512.
7. Ten Berge, D., Kurek, D., Blauwkamp, T., et al. (2011) Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nature Cell Biology, 13 (9), 1070-1075.
8. Liu, C., Li, Y., Semenov, M., et al. (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell, 108 (6), 837-847.
9. Veeman, M.T., Axelrod, J.D., and Moon, R.T. (2003)Asecond canon: functions and mechanisms of ß-catenin-independent Wnt signaling. Developmental Cell, 5 (3), 367-377.
10. Cohen, E.D., Tian, Y., and Morrisey, E.E. (2008) Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development, 135 (5), 789-798.
11. Gessert, S. and Kuhl, M. (2010) The multiple phases and faces of Wnt signaling during cardiac differentiation and development. Circulation Research, 107 (2), 186-199.
12. Pandur, P., Lasche, M., Eisenberg, L.M., and Kuhl, M. (2002) Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature, 418 (6898), 636-641.
13. Maye, P., Zheng, J., Li, L., and Wu, D. (2004) Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. Journal of Biological Chemistry, 279 (23), 24659-24665.
14. Kusserow, A., Pang, K., Sturm, C., et al. (2005) Unexpected complexity of the Wnt gene family in a sea anemone. Nature, 433 (7022), 156-160.
15. Clevers, H. and Nusse, R. (2012) Wnt/ß-catenin signaling and disease. Cell, 149 (6), 1192-1205.
16. Hao, J., Li, T.-G., Qi, X., et al. (2006) WNT/ß-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Developmental Biology, 290 (1), 81-91.
17. Ogawa, K., Nishinakamura, R., Iwamatsu, Y., et al. (2006) Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochemical and Biophysical Research Communications, 343 (1), 159-166.
18. Singla, D.K., Schneider, D.J., LeWinter, M.M., and Sobel, B.E. (2006) wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochemical and Biophysical Research Communications, 345 (2), 789-795
19. Kielman, M.F., Rindapäa, M., Gaspar, C., et al. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of ß-catenin signaling. Nature Genetics, 32 (4), 594-605.
20. Dravid, G., Ye, Z., Hammond, H., et al. (2005) Defining the role of Wnt/ß-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells, 23 (10), 1489-1501.
21. Cai, L., Ye, Z., Zhou, B.Y., et al. (2007) Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Research, 17 (1), 62-72.
22. Villa-Diaz, L.G., Pacut, C., Slawny, N.A., et al. (2009) Analysis of the factors that limit the ability of feeder cells to maintain the undifferentiated state of human embryonic stem cells. Stem Cells and Development, 18 (4), 641-651.
23. Sato, N., Meijer, L., Skaltsounis, L., et al. (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Medicine, 10 (1), 55-63.
24. Ullmann, U., Gilles, C., Rycke, M.D., et al. (2008) GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions. Molecular Human Reproduction, 14 (3), 169-179.
25. Sumi, T., Tsuneyoshi, N., Nakatsuji, N., and Suemori, H. (2008) Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/ß-catenin, Activin/Nodal and BMP signaling. Development, 135 (17), 2969-2979.
26. Blauwkamp, T.A., Nigam, S., Ardehali, R., et al. (2012) Endogenous Wnt signalling in human embryonic stem cells generates an equilibrium of distinct lineage-specified progenitors. Nature Communications, 3, 1070.
27. Davidson, K.C., Adams, A.M., Goodson, J.M., et al. (2012) Wnt/ß-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct 4. Proceedings of the National Academy of Sciences of the United States of America, 109, 4485-4499.
28. Woll, P.S., Morris, J.K., Painschab, M.S., et al. (2008) Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood, 111 (1), 122-131.
29. Chen, V.C., Stull, R., Joo, D., et al. (2008) Notch signaling respecifies the hemangioblast to a cardiac fate. Nature Biotechnology, 26 (10), 1169-1178.
30. Onizuka, T., Yuasa, S., Kusumoto, D., et al. (2012) Wnt2 accelerates cardiac myocyte differentiation from ES-cell derived mesodermal cells via non-canonical pathway. Journal of Molecular and Cellular Cardiology, 52 (3), 650-659.
31. Qyang, Y., Martin-Puig, S., Chiravuri, M., et al. (2007) The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell, 1 (2), 165-179.
32. Rai, M., Walthall, J.M., Hu, J., and Hatzopoulos, A.K. (2012) Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells. Stem Cells and Development, 21 (1), 54-66.
33. Lickert, H., Kutsch, S., Kanzler, B., et al. (2002) Formation of multiple hearts in mice following deletion of beta-catenin in the embryonic endoderm. Developmental Cell, 3 (2), 171-181.
34. Muller, I.I., Melville, D.B., Tanwar, V., et al. (2012) Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Disease Models & Mechanisms, 6 (2), 332-341.
35. Marvin, M.J., Di Rocco, G., Gardiner, A., et al. (2001) Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes and Development, 15 (3), 316-327.
36. Lavery, D.L., Martin, J., Turnbull, Y.D., and Hoppler, S. (2008) Wnt6 signaling regulates heart muscle development during organogenesis. Developmental Biology, 323 (2), 177-188.
37. Gibb, N., Lavery, D.L., and Hoppler, S. (2013) sfrp1 promotes cardiomyocyte differentiation in Xenopus via negative-feedback regulation of Wnt signalling. Development, 140 (7), 1537-1549.
38. Ueno, S., Weidinger, G., Osugi, T., et al. (2007) Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104 (23), 9685-9690.
39. Naito, A.T., Shiojima, I., Akazawa, H., et al. (2006) Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 103 (52), 19812-19817.
40. Ni, T.T., Rellinger, E.J., Mukherjee, A., et al. (2011) Discovering small molecules that promote cardiomyocyte generation by modulating Wnt signaling. Chemistry and Biology, 18 (12), 1658-1668.
41. Wang, H., Hao, J., and Hong, C.C. (2011) Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/ß-catenin signaling. ACS Chemical Biology, 6 (2), 192-197.
42. Minami, I., Yamada, K., Otsuji, T.G., et al. (2012) A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine-and xeno-free conditions. Cell Reports, 2 (5), 1448-1460.
43. Willems, E., Spiering, S., Davidovics, H., et al. (2011) Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circulation Research, 109 (4), 360-364.
44. Ren, Y., Lee, M.Y., Schliffke, S., et al. (2011) Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. Journal of Molecular and Cellular Cardiology, 51 (3), 280-287.
45. Saraswati, S., Alfaro, M.P., Thorne, C.A., et al. (2010) Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling. PLoS One, 5 (11), e15521.
46. Uccelli, A., Moretta, L., and Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nature Reviews Immunology, 8 (9), 726-736.
47. Bennett, C.N., Longo, K.A., Wright, W.S., et al. (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proceedings of the National Academy of Sciences of the United States of America, 102 (9), 3324-3329.
48. Bennett, C.N., Ouyang, H., Ma Y.L., et al. (2007) Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. The Journal of Bone and Mineral Research of the American Society for Bone and Mineral Research, 22 (12), 1924-1932.
49. Kang, S., Bennett, C.N., Gerin, I., et al. (2007) Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. Journal of Biological Chemistry, 282 (19), 14515-14524.
50. Cawthorn,W.P., Bree, A.J.,Yao,Y., et al. (2012) Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a ß-catenin-dependent mechanism. Bone, 50 (2), 477-489.
51. Longo, K.A., Wright, W.S., Kang, S., et al. (2004) Wnt10b inhibits development of white and brown adipose tissues. Journal of Biological Chemistry, 279 (34), 35503-35509.
52. D'Alimonte, I., Lannutti, A., Pipino, C., et al. (2013) Wnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells. Stem Cell Reviews, 9, 642-654.
53. Christodoulides, C., Scarda, A., Granzotto, M., et al. (2006) WNT10B mutations in human obesity. Diabetologia, 49 (4), 678-684.
54. Kim, I.C., Cha, M.H., Kim, D.M., et al. (2011) A functional promoter polymorphism -607G>C of WNT10B is associated with abdominal fat in Korean female subjects. The Journal of Nutritional Biochemistry, 22 (3), 252-258.
55. Van Camp, J.K., Beckers, S., Zegers, D., et al. (2012) Genetic association between WNT10B polymorphisms and obesity in a Belgian case-control population is restricted to males. Molecular Genetics and Metabolism, 105 (3), 489-493.
56. Katoh, M. and Katoh, M. (2007) AP1-and NF-kappaB-binding sites conserved among mammalian WNT10B orthologs elucidate the TNFalpha-WNT10B signaling loop implicated in carcinogenesis and adipogenesis. International Journal of Molecular Medicine, 19 (4), 699-703.
57. Saitoh, T., Kirikoshi, H., Mine, T., and Katoh, M. (2001) Proto-oncogene WNT10B is upregulated by tumor necrosis factor alpha in human gastric cancer cell line MKN45. International Journal of Oncology, 19 (6), 1187-1192.
58. Chang, J., Liu, F., Lee, M., et al. (2013) NF-?B inhibits osteogenic differentiation of mesenchymal stem cells by promoting ß-catenin degradation. Proceedings of the National Academy of Sciences of the United States of America, 110 (23), 9469-9474.
59. Chang, J., Sonoyama, W., Wang, Z., et al. (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. Journal of Biological Chemistry, 282 (42), 30938-30948.
60. Liu, N., Shi, S., Deng, M., et al. (2011) High levels of ß-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. The Journal of Bone and Mineral Research of the American Society for Bone and Mineral Research, 26 (9), 2082-2095.
61. Alfaro, M.P., Pagni, M.,Vincent, A., et al. (2008) The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proceedings of the National Academy of Sciences of the United States of America, 105 (47), 18366-18371.
62. Alfaro, M.P., Vincent, A., Saraswati, S., et al. (2010) sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. Journal of Biological Chemistry, 285 (46), 35645-35653.
63. Mirotsou, M., Zhang, Z., Deb, A., et al. (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America, 104 (5), 1643-1648.
64. Mirotsou, M., Jayawardena, T.M., Schmeckpeper, J., et al. (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. Journal of Molecular and Cellular Cardiology, 50 (2), 280-289.
65. Clements,W.K., Kim, A.D., Ong, K.G., et al. (2011) A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature, 474 (7350), 220-224.
66. Luis, T.C. and Staal, F.J.T. (2009) WNT proteins: environmental factors regulating HSC fate in the niche. Annals of the New York Academy of Sciences, 1176, 70-76.
67. Staal, F.J.T. and Sen, J.M. (2008) The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. European Journal of Immunology, 38 (7), 1788-1794.
68. Reya, T., Duncan, A.W., Ailles, L., et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423 (6938), 409-414.
69. Scheller, M., Huelsken, J., Rosenbauer, F., et al. (2006) Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nature Immunology, 7 (10), 1037-1047.
70. Kirstetter, P., Anderson, K., Porse, B.T., et al. (2006) Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nature Immunology, 7 (10), 1048-1056.
71. Zhao, C., Blum, J., Chen, A., et al. (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cells, 12 (6), 528-541.
72. Malhotra, S., Baba, Y., Garrett, K.P., et al. (2008) Contrasting responses of lymphoid progenitors to canonical and noncanonical Wnt signals. Journal of Immunology (Baltimore, MD: 1950), 181 (6), 3955-3964.
73. Nemeth, M.J., Topol, L., Anderson, S.M., et al. (2007) Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proceedings of the National Academy of Sciences of the United States of America, 104 (39), 15436-15441.
74. Louis, I., Heinonen, K.M., Chagraoui, J., et al. (2008) The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-cateninindependent signaling. Immunity, 29 (1), 57-67.
75. Luis, T.C., Naber, B.A.E., Roozen, P.P.C., et al. (2011) Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell, 9 (4), 345-356.
76. Luis, T.C., Ichii, M., Brugman, M.H., et al. (2012) Wnt signaling strength regulates normal hematopoiesis and its deregulation is involved in leukemia development. Leukemia, 26 (3), 414-421.
77. Hochedlinger, K., Yamada, Y., Beard, C., and Jaenisch, R. (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121 (3), 465-477.
78. Lee, S.M., Tole, S., Grove, E., and McMahon, A.P. (2000) A local Wnt-3a signal is required for development of the mammalian hippocampus. Development (Cambridge England), 127 (3), 457-467.
79. Lie, D.-C., Colamarino, S.A., Song H.-J., et al. (2005) Wnt signalling regulates adult hippocampal neurogenesis. Nature, 437 (7063), 1370-1375.
80. Chenn, A. and Walsh, C.A. (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science, 297 (5580), 365-369.
81. Bautch, V.L. (2011) Stem cells and the vasculature. Nature Medicine, 17 (11), 1437-1443.
82. Medici, D. and Kalluri, R. (2012) Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Seminars in Cancer Biology, 22 (5-6), 379-384.
83. Medici, D., Shore, E.M., Lounev, V.Y., et al. (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Medicine, 16 (12), 1400-1406.
84. Zeisberg, E.M., Tarnavski, O., Zeisberg, M., et al. (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13 (8), 952-961.
85. Zeisberg, E.M., Potenta, S., Xie, L., et al. (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Research, 67 (21), 10123-10128.
86. Medici, D., Potenta, S., and Kalluri, R. (2011) Transforming growth factor-ß2 promotes Snailmediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochemical Journal, 437 (3), 515-520.
87. Markwald, R.R., Fitzharris, T.P., and Smith, W.N.A. (1975) Structural analysis of endocardial cytodifferentiation. Developmental Biology, 42 (1), 160-180.
88. Aisagbonhi, O., Rai, M., Ryzhov, S., et al. (2011) Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Disease Models & Mechanisms, 4 (4), 469-483.
89. Armulik, A., Abramsson, A., and Betsholtz, C. (2005) Endothelial/pericyte interactions. Circulation Research, 97 (6), 512-523.
90. Moonen, J.-R.A.J., Krenning, G., Brinker, M.G.L., et al. (2010) Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovascular Research, 86 (3), 506-515.
91. Cheng, S.-L., Shao, J.-S., Behrmann, A., et al. (2013) Dkk1 and Msx2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 33 (7), 1679-1689.
92. Hirata-Tominaga, K., Nakamura, T., Okumura, N., et al. (2013) Corneal endothelial cell fate is maintained by LGR5 through the regulation of hedgehog and Wnt pathway. Stem Cells, 31 (7), 1396-1407.
93. Das Gupta, R. and Fuchs, E. (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development (Cambridge England), 126 (20), 4557-4568.
94. Gregorieff, A. and Clevers, H. (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes and Development, 19 (8), 877-890.